| Literature DB >> 30567693 |
Ri-Hua Xie1,2,3, Hongzhuan Tan4, Monica Taljaard5,6, Yan Liao5, Daniel Krewski3, Qingfeng Du2, Shi Wu Wen5,6,7.
Abstract
BACKGROUND: In recent years, attempts have been made to use mobile phone text messaging (short message service, SMS) to achieve positive results for a range of health issues. Reports on the impact of maternal education programs based on this widely available, inexpensive, and instant communication tool are sparse.Entities:
Keywords: cluster trial; infant health; maternal education; maternal health; text messaging
Year: 2018 PMID: 30567693 PMCID: PMC6315224 DOI: 10.2196/11213
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Figure 1Flowchart of study participants of the text messaging trial in Hunan, China.
Comparison of maternal and infant characteristics between the intervention and control arms at the individual level, Hunan, China, 2011-2012.
| Characteristics | Intervention arm (N=6771), n (%) | Control arm (N=6966), n (%) | |
| >1 | 3285 (48.52) | 3478 (49.93) | |
| 1 | 3486 (51.48) | 3488 (50.07) | |
| >1 | 3883 (57.35) | 4316 (61.96) | |
| 1 | 2253 (33.27) | 2039 (29.27) | |
| Rural resident | 6388 (94.34) | 6389 (91.72) | |
| High-risk pregnancy | 2488 (36.75) | 2841 (40.78) | |
| Female | 3057 (45.15) | 3639 (52.24) | |
| Male | 3684 (54.41) | 3304 (47.43) | |
Comparison of maternal and infant outcomes between the intervention and control arms at the county level, Hunan, China, 2011-2012.
| Outcome | Intervention arm, % mean (SD) | Control arm, % mean (SD) | Percentage mean difference (95% CI) | |
| Early pregnancy visit | 94.8 (2.3) | 95.0 (1.1) | 0.2 (−5.8 to 6.2) | .94 |
| Prenatal screening | 52.5 (12.7) | 41.3 (14.3) | −11.2 (−30.9 to 8.5) | .23 |
| Syphilis test | 93.2 (7.1) | 96.8 (3.3) | 3.6 (−4.5 to 11.6) | .34 |
| Hepatitis B test | 94.9 (5.4) | 98.3 (1.8) | 3.4 (−2.4 to 9.3) | .21 |
| Folic acid supplementation | 75.6 (13.6) | 78.4 (6.3) | 2.7 (−12.8 to 18.2) | .69 |
| Cesarean delivery | 37.4 (6.8) | 42.8 (16.0) | 5.4 (−12.5 to 23.3) | .50 |
| Obstetric hemorrhage | 0.7 (0.5) | 1.2 (0.8) | 0.5 (−0.5 to 1.4) | .32 |
| Maternal death | 0.0 (0.1) | 0.1 (0.2) | 0.1 (−0.1 to 0.3) | .47 |
| Perinatal death | 1.3 (0.6) | 1.5 (0.4) | 0.1 (−0.6 to 0.9) | .66 |
| Birth weight <2500 g | 3.0 (0.5) | 3.7 (2.1) | 0.6 (−1.6 to 2.9) | .54 |
| Birth weight >4000 g | 1.5 (0.6) | 1.6 (0.6) | 0.1 (−0.8 to 1) | .80 |
| Thyroid test | 86.5 (10.2) | 88.1 (5.0) | 1.7 (−10.1 to 13.4) | .75 |
| Phenylketonuria test | 86.4 (10.2) | 88.2 (4.9) | 1.8 (−9.9 to 13.5) | .73 |
| Hearing tests | 2.3 (0.9) | 2.1 (0.9) | −0.2 (−1.5 to 1.1) | .69 |
Comparison of maternal and infant outcomes between the intervention and control arms at the individual level, Hunan, China, 2011-2012 (adjusted for gravidity, parity, residence, household income, high-risk pregnancy status, and gender of infant).
| Outcomes | Intervention arm (N=6771), n (%) | Control arm (N=6966), n (%) | Crude odds ratio (95% CI) | Adjusted odds ratio (95% CI) |
| Early pregnancy visit | 6308 (93.16) | 6644 (95.38) | 0.99 (0.98-1.00) | 0.99 (0.99-1.00) |
| Prenatal screening | 3291 (48.6) | 2381 (34.18) | 1.34 (1.28-1.39) | 1.25 (1.21-1.31) |
| Syphilis test | 6121 (90.4) | 6625 (95.11) | 0.98 (0.97-0.98) | 0.98 (0.97-0.99) |
| Hepatitis B test | 6229 (92) | 6767 (97.14) | 0.97 (0.96-0.98) | 0.98 (0.97-0.99) |
| Folic acid supplementation | 4733 (69.9) | 5431 (77.96) | 0.93 (0.91-0.95) | 0.92 (0.90-0.93) |
| Cesarean delivery | 2488 (36.75) | 2927 (42.02) | 0.88 (0.84-0.92) | 0.95 (0.91-0.98) |
| Obstetric hemorrhage | 47 (0.69) | 77 (1.11) | 0.64 (0.45-0.92) | 0.42 (0.22-0.80) |
| Maternal death | 3 (0.04) | 6 (0.09) | 0.52 (0.13-2.10) | —a |
| Perinatal death | 84 (1.24) | 101 (1.45) | 0.96 (0.72-1.27) | 0.73 (0.50-1.06) |
| Birth weight <2500 g | 196 (2.9) | 210 (3.02) | 0.98 (0.81-1.19) | 1.20 (0.97-1.47) |
| Birth weight >4000 g | 97 (1.43) | 105 (1.51) | 0.97 (0.74-1.28) | 1.01 (0.76-1.36) |
| Thyroid test | 3977 (58.74) | 4156 (59.66) | 0.96 (0.95-0.98) | 0.96 (0.95-0.98) |
| Phenylketonuria test | 3911 (57.76) | 4162 (59.75) | 0.96 (0.95-0.98) | 0.96 (0.95-0.98) |
| Hearing test | 3935 (58.12) | 3989 (57.26) | 0.97 (0.95-0.98) | 0.97 (0.95-0.99) |
aNot estimable.